Aurinia Pharmaceuticals Inc (AUPH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

#1203-4464 MARKHAM STREET VICTORIA BC, BRITISH COLUMBIA, CANADA V8Z 7X8

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of immunosuppressive therapeutics.

Data as of 2021-04-17 10:43:06 -0400
Market Cap1.574 Billion Shares Outstanding127.451 Million Avg 30-day Volume2.104 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.76275 52-week High/Low20.5 / 12.01 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from AUPH instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 3 -66.67% 2 (0.12%) 3 (0.19%) -33.33%
Funds Holding: 139 141 -1.42% 35 (2.1%) 49 (3.05%) -28.57%
13F shares: 57.931 Million 64.751 Million -10.53% 29.769 Million 40.375 Million -26.27%
% Ownership 45.7707 51.1589 -10.53% 23.5201 31.8996 -26.27%
New Positions: 22 30 -26.67% 2 15 -86.67%
Increased Positions 50 66 -24.24% 14 18 -22.22%
Closed Positions 22 18 22.22% 15 8 87.5%
Reduced Positions 41 27 51.85% 13 12 8.33%
Total Calls 3.318 Million 2.673 Million 24.12% 1.857 Million 1.624 Million 14.38%
Total Puts 3.347 Million 2.222 Million 50.65% 1.331 Million 970 Thousand 37.25%
PUT/CALL Ratio 1.01 0.83 21.69% 0.72 0.6 20.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AUPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AUPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

5 Thousand total shares from 1 transactions

Open Market Sells (S)

40 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

40 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SOLOMONS NEIL CHIEF MEDICAL OFFICER

  • Officer
187,299 2021-03-12 2

MILNE GEORGE M JR

  • Director
45,000 2021-03-05 2

HAYDEN MICHAEL R

  • Director
95,000 2021-01-29 2

LEVERSAGE JILL

  • Director
2,600 2021-01-29 2

ROBERTSON STEPHEN P. EVP, GENERAL COUNSEL

  • Officer
2,720 2021-01-28 2

BILLEN DANIEL

  • Director
20,000 2021-01-01 1

COLAO MASSIMILANO CHIEF COMMERCIAL OFFICER

  • Officer
8,200 2021-01-01 1

DONLEY MATTHEW MAXWELL EX VP, INTERN'L OPERATIONS

  • Officer
0 2021-01-01 1

GREENLEAF PETER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
8,328 2021-01-01 1

HAGAN JOSEPH P

  • Director
3,500 2021-01-01 1

HUIZINGA ROBERT BINDERT EX VICE PRESIDENT OF RESEARCH

  • Officer
103,592 2021-01-01 1

JAYNE DAVID R.W.

  • Director
30,000 2021-01-01 1

MACKAY-DUNN R. HECTOR

  • Director
1,500 2021-01-01 1

MILLER JOSEPH M CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-01 1

MARTIN MICHAEL ROBERT CHIEF BUSINESS OFFICER

  • Officer
201,861 2021-01-01 1

WALBERT TIMOTHY P

  • Director
0 2021-01-01 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SOLOMONS NEIL - Officer CHIEF MEDICAL OFFICER

2021-03-15 16:36:13 -0400 2021-03-12 S 40,000 $13.49 d 187,299 direct 1.3015 -7.0137 1.3015 2 -7.0137 6

SOLOMONS NEIL - Officer CHIEF MEDICAL OFFICER

2021-03-15 16:36:13 -0400 2021-03-12 M 40,000 $3.02 a 227,299 direct 1.3015 -7.0137 1.3015 2 -7.0137 6

SOLOMONS NEIL - Officer CHIEF MEDICAL OFFICER

2021-03-15 16:36:13 -0400 2021-03-12 M 40,000 d 0 direct

MILNE GEORGE M JR - Director

2021-03-09 16:25:08 -0500 2021-03-05 P 5,000 $13.00 a 45,000 direct 4.119 6.865 8.6957 4 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 22:15:03 UTC -1.024 1.084 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 21:45:03 UTC -1.024 1.084 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 21:15:02 UTC -1.024 1.084 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 20:45:03 UTC -1.0143 1.0743 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 20:15:04 UTC -1.0143 1.0743 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 19:45:03 UTC -1.0143 1.0743 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 19:15:03 UTC -1.0143 1.0743 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 18:45:03 UTC -1.0143 1.0743 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 18:15:03 UTC -1.0143 1.0743 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 17:45:02 UTC -1.0143 1.0743 1400000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 17:15:02 UTC -1.0143 1.0743 1500000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 16:45:03 UTC -1.0021 1.0621 1500000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 16:15:03 UTC -1.0021 1.0621 1500000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 15:45:03 UTC -1.0021 1.0621 1500000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 15:15:02 UTC -1.0021 1.0621 950000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 14:45:03 UTC -1.1205 1.1805 950000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 14:15:03 UTC -1.1205 1.1805 950000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 13:45:03 UTC -1.1205 1.1805 950000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 13:15:04 UTC -1.1205 1.1805 950000
AURINIA PHARMACEUTICALS INC AUPH 2021-04-20 12:45:03 UTC -1.1205 1.1805 950000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund AUPH -290.0 shares, $-4207.9 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund AUPH -73.0 shares, $-1059.23 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund AUPH -293.0 shares, $-4251.43 2020-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AUPH -7200.0 shares, $-99576.0 2020-12-31 N-PORT

Elevate your investments